These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20819526)

  • 21. Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation.
    Takahashi S; Kudo M; Chung H; Inoue T; Nagashima M; Kitai S; Tatsumi C; Minami Y; Ueshima K; Fukunaga T; Haji S
    Dig Dis; 2007; 25(4):303-9. PubMed ID: 17960064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Liver resection for hepatocellular carcinoma in cirrhotic patients].
    Târcoveanu E; Lupaşcu C; Georgescu S; Zugun F; Crumpei F; Epure O; Nicorici C; Canschi G; Ferariu D
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(4):770-80. PubMed ID: 16610175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiofrequency ablation for unresectable tumors of the liver.
    Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ
    Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: long-term results.
    Peng ZW; Zhang YJ; Chen MS; Lin XJ; Liang HH; Shi M
    Eur J Surg Oncol; 2010 Nov; 36(11):1054-60. PubMed ID: 20846819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow. Comparison with standard percutaneous radiofrequency ablation therapy.
    Yamasaki T; Kurokawa F; Shirahashi H; Kusano N; Hironaka K; Okita K
    Cancer; 2002 Dec; 95(11):2353-60. PubMed ID: 12436442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Radiofrequency ablation with or without transcather arterial chemoembolization for management of hepatocellular carcinoma].
    Li ZR; Kang Z; Qian JS; Zhu KS; Jiang ZB; Huang MS; Guan SH; Shan H
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1749-51. PubMed ID: 18024306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection.
    Kagawa T; Koizumi J; Kojima S; Nagata N; Numata M; Watanabe N; Watanabe T; Mine T;
    Cancer; 2010 Aug; 116(15):3638-44. PubMed ID: 20564097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response.
    Guglielmi A; Ruzzenente A; Pachera S; Valdegamberi A; Sandri M; D'Onofrio M; Iacono C
    Am J Gastroenterol; 2008 Mar; 103(3):597-604. PubMed ID: 17970836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical features of liver abscess developed after radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma].
    Kim MH; Choi MS; Choi YS; Kim DY; Lee JM; Paik SW; Lee JH; Koh KC; Yoo BC; Choi D; Rhee JC
    Korean J Hepatol; 2006 Mar; 12(1):55-64. PubMed ID: 16565606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of laparoscopic radiofrequency ablation for hepatocellular carcinoma compared to percutaneous radiofrequency ablation with artificial ascites.
    Hirooka M; Kisaka Y; Uehara T; Ishida K; Kumagi T; Watanabe Y; Abe M; Matsuura B; Hiasa Y; Onji M
    Dig Endosc; 2009 Apr; 21(2):82-6. PubMed ID: 19691779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical radiofrequency ablation for treatment of hepatocellular carcinoma: an endoscopic or open approach.
    Tanaka S; Shimada M; Shirabe K; Taketomi A; Maehara S; Tsujita E; Ito S; Kitagawa D; Maehara Y
    Hepatogastroenterology; 2009; 56(93):1169-73. PubMed ID: 19760963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
    Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S
    Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined treatment, TACE and RF ablation, in HCC: preliminary results.
    Gasparini D; Sponza M; Marzio A; Zanardi R; Bazzocchi M; Cemal Y
    Radiol Med; 2002; 104(5-6):412-20. PubMed ID: 12589262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radio-frequency thermal ablation (RFTA) of small hepatocellular carcinoma in patients with cirrhosis. Experience at a single tertiary referral center.
    Licata A; Di Marco V; Parisi P; Latteri F; Nebbia ME; Cabibbo G; Di Bona D; Prinzi G; Li Petri S; Sandonato L; Latteri MA; Craxì A; Cammà C
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):171-8. PubMed ID: 15990706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of small HCC through radiofrequency ablation and laser ablation. Comparison of techniques and long-term results.
    Ferrari FS; Megliola A; Scorzelli A; Stella A; Vigni F; Drudi FM; Venezia D
    Radiol Med; 2007 Apr; 112(3):377-93. PubMed ID: 17447018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiofrequency ablation with hand-assisted laparoscopic surgery for the treatment of hepatocellular carcinoma in the caudate lobe.
    Ishiko T; Beppu T; Sugiyama S; Masuda T; Takahashi M; Komori H; Takamori H; Hirota M; Kanemitu K; Baba H
    Surg Laparosc Endosc Percutan Tech; 2008 Jun; 18(3):272-6. PubMed ID: 18574414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma.
    Cheung TT; Ng KK; Poon RT; Fan ST
    J Hepatobiliary Pancreat Surg; 2009; 16(5):655-60. PubMed ID: 19370304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of liver resection in combination with radiofrequency ablation for hepatic malignancies.
    Eisele RM; Zhukowa J; Chopra S; Schmidt SC; Neumann U; Pratschke J; Schumacher G
    Eur J Surg Oncol; 2010 Mar; 36(3):269-74. PubMed ID: 19726155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma.
    Helmberger T; Dogan S; Straub G; Schrader A; Jüngst C; Reiser M; Waggershauser T; Jakobs T; Hoffmann RT; Löhe F; Graeb C; Rau HG; Schauer R; Jauch KW; Caselmann WH; Göke B; Jüngst D
    Digestion; 2007; 75(2-3):104-12. PubMed ID: 17598962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time-lag performance of radiofrequency ablation after percutaneous ethanol injection for the treatment of hepatocellular carcinoma.
    Kurokohchi K; Masaki T; Watanabe S; Nakai S; Deguchi A; Morishita A; Yoneyama H; Ohgi T; Ono M; Yoshitake A; Kako T; Ohmachi N; Kiuchi T; Maeta T; Yoshida M; Mori Y; Kohi F; Kuriyama S
    Int J Oncol; 2006 Apr; 28(4):971-6. PubMed ID: 16525648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.